These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6249689)

  • 1. Variability in derivative strains of Bordetella pertussis.
    Parker CD; Doyle S; Field LH; Hewlett E
    Dev Biol Stand; 1980; 45():119-27. PubMed ID: 6249689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selection of Bvg- variants of Bordetella pertussis].
    Passerini de Rossi BN; Friedman LE; Darnaud S; de Torres RA; Franco MA
    Rev Argent Microbiol; 1997; 29(2):75-83. PubMed ID: 9424628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.
    Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C
    Vaccine; 2008 Oct; 26(45):5722-7. PubMed ID: 18762220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
    Khosravani A; Parker MC; Parton R; Coote J
    Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and protective activities of outer membrane proteins from Bordetella.
    González-y-Merchand J; Ruiloba de León S; Estrada-García I; López-Flores C; Ortega-Ortega R; Ruíz-Puente J
    Rev Latinoam Microbiol; 1995; 37(1):33-41. PubMed ID: 7784730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
    Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on toxicity of Bordetella pertussis cultures and antigens.
    Spasojević V
    Dev Biol Stand; 1977; 34():197-205. PubMed ID: 190070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin.
    Medeiros MA; Armôa GR; Dellagostin OA; McIntosh D
    Can J Microbiol; 2005 Dec; 51(12):1015-20. PubMed ID: 16462859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence of a Bordetella pertussis strain expressing a mutant adenylyl cyclase with decreased calmodulin affinity.
    Oldenburg DJ; Gross MK; Smith AL; Storm DR
    Microb Pathog; 1993 Jun; 14(6):489-93. PubMed ID: 8412621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and purification of Bordetella pertussis toxin.
    Ju CL; Sheu GC; Cheng Y; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 May; 30(2):72-83. PubMed ID: 10592813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A field survey carried out on the confirmation of a pertussis case in a village of Kirikkale Province, Turkey].
    Coplü N; Nar S; Efsun A; Kurtoğlu D; Esen B
    Mikrobiyol Bul; 2007 Apr; 41(2):175-83. PubMed ID: 17682703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial growth and virulence factors production by different Bordetella pertussis strains.
    Letowska I; Chodorowska M; Kaczurba E; Kuklińska D; Tyski S
    Acta Microbiol Pol; 1997; 46(1):45-55. PubMed ID: 9271847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.